March 2026
The global neuromodulation market size is valued at USD 9.07 billion in 2025, and it is expected to surpass USD 28.07 billion by 2035, at a CAGR of 11.96%.
September 2026
The internal neuromodulation devices market reached USD 15.67 billion in 2026, featuring leading internal neuromodulation devices market companies such as Medtronic plc, Abbott Laboratories, Boston Scientific Corporation.